Haematology

News

FDA clears Gamida’s cord blood therapy for cancer patients

The FDA has approved a stem cell-based therapy for cancer patients from Israeli biotech Gamida Cell that is designed to help them recover more quickly from aggressive chem

News

Despite FDA doubts, advisors back first-line Polivy use

Panel votes 11 to 2 to back Roche's drug for treatment-naïve diffuse large B-cell lymphoma.

News

Hemab raises $135m for rare bleeding disorder trials

Cash will be used to advance drugs for Glanzmann thrombasthenia and von Willebrand disease.

News

Takeda claims first phase 3 win in rare disease cTTP

Takeda has reported positive results from a phase 3 trial of its experimental therapy TAK-755 for ultra-rare disease congenital thrombotic thrombocytopenic purpura (cTTP), setting up regula

News

Geron finally gets close to a product approval with imetelst...

More than 30 years after it was first formed, Geron is on the cusp of bringing its first product to market, after imetelstat hit the mark in a phase 3 trial in patients with myelodysplastic

News

ASH roundup: late breakers take the stage

The final day of the ASH congress always includes a session on late-breaking studies, and this year was no exception, with presentations on Novartis' iptacopan in paroxysmal nocturnal haemo

FDA clears Gamida’s cord blood therapy for cancer patients

Despite FDA doubts, advisors back first-line Polivy use

Hemab raises $135m for rare bleeding disorder trials

Takeda claims first phase 3 win in rare disease cTTP

Geron finally gets close to a product approval with imetelst...

ASH roundup: late breakers take the stage

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Haematology

Editor's Picks